Manager TitleAgeSince
Chief Executive Officer 54 08/06/2020
Director of Finance/CFO - 01/09/2024
Director TitleAgeSince
Chairman 59 01/06/2024
Director/Board Member - 01/06/2024
Director/Board Member - 01/06/2024
Change 5-day change 1-year change 3-year change Capi.($)
-3.75%-30.00% - - 315K
+3.71%-4.68%-35.87%-4.93% 30.25B
-1.42%-14.59%-50.19%+138.93% 11.68B
+1.76%-3.42%-28.24%+56.17% 5.28B
-1.99%-3.05% - - 2.08B
+2.86%-10.62%+45.03%-34.46% 1.86B
-3.11%-1.18% - - 1.72B
-3.12%-3.55%-39.57% - 1.03B
-2.01%-3.95%+36.02%+105.63% 865M
-4.53%-4.82%-45.89%-58.09% 723M
Average -1.16%-5.60%-16.96%+33.87% 6.17B
Weighted average by Cap. +1.67%-6.65%-34.42%+34.63%
Logo Duearity AB
Duearity AB is a Sweden-based medical technology company. The Company's product is Tinearity G1. Tinearity G1 is a medical device that helps with tinnitus treatment. Tinearity G1 is based on Tinnitus Retraining Therapy, a white noise treatment that has been used clinically for several decades. Tinearity G1 consists of sound elements that lead white noise to the inner ear via the skull bone. The method is non-invasive and the ear canal is not affected.
Employees
2
  1. Stock Market
  2. Stocks
  3. DEAR Stock